Each row is scaled to the larger of the two, so the shorter bar is the ratio between them. "Not stated" is left empty rather than drawn as zero — a filing that omits a figure is not a filing that reports none.
ALZHEON, INC. states $12.83M more than Iambic Therapeutics, Inc. — 1.2× the size, Iambic Therapeutics, Inc. filed 1 day earlier and Iambic Therapeutics, Inc. names 13 more investors already in.
| Rank | Company | Score | Raise size | Filed | People named | Investors in |
|---|---|---|---|---|---|---|
| 1 | Iambic Therapeutics, Inc.leads | 94 | $65.97M · 93rd pctadds 36 | 2026-09-09 · 3d agoadds 23 | 13adds 23 | 16adds 12 |
| 2 | ALZHEON, INC. | 92 | $78.80M · 100th pctadds 38 | 2026-09-10 · 2d agoadds 23 | 12adds 23 | 3adds 8 |
A score out of 100 comparing what each company's record shows for raise size within its industry group, filing recency, people named on the filing and investors disclosed.
- Raise size within its industry groupup to 39
- Filing recencyup to 23
- People named on the filingup to 23
- Investors disclosedup to 15
- 75 and up
- 55 to 74
- 35 to 54
- under 35
| Measure | ALZHEON, INC. | Iambic Therapeutics, Inc. |
|---|---|---|
| On the record | $78.80M | $65.97M |
| Industry group | Biotechnology | Biotechnology |
| Filing | Form D | Form D |
| Filed | 2026-09-10 | 2026-09-09 |
| Investors already in | 3 | 16 |
| Non-accredited investors | No | No |
| Entity type | Corporation | Corporation |
| Incorporated in | DELAWARE | DELAWARE |
| Based | FRAMINGHAM, MASSACHUSETTS | SAN DIEGO, CALIFORNIA |
| Exemptions claimed | 06b | 06b |
ALZHEON, INC.
Against the 16 raises on file in Biotechnology. Median $5.60M, largest $78.80M.
Iambic Therapeutics, Inc.
Against the 16 raises on file in Biotechnology. Median $5.60M, largest $78.80M.
How does your raise compare?
Enter an amount to place it against the filings on record.
Percentiles are drawn from the 1409 Form D filings held here that state an amount, filed between 3 and 11 September 2026 — 1383 of them in the 21 industry groups large enough to rank against (5 filings minimum).
The full profile
Source Check, INVEST, RECRUIT and Press Requests on ALZHEON, INC.
- Source Check — verify what Martin Tolar, M.D., Ph.D. states, against the registers that hold it.
- INVEST — take this comparison past the two, across the whole group.
- RECRUIT — see who is already on both teams.
- Press Requests — connect with Martin Tolar, M.D., Ph.D. for a story.
You land back on this comparison when you are in.
Not ready to upgrade? Keep the larger of the two in view instead.
Watchlist ALZHEON, INC.Both profiles in full: ALZHEON, INC. · Iambic Therapeutics, Inc..
Both sides are read from the filing index on sec.gov — ALZHEON, INC. and Iambic Therapeutics, Inc..